Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours.
about
DNA Damage Response and Immune Defense: Links and MechanismsSystems biology of cisplatin resistance: past, present and futureAssociation between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.Association between the ERCC1 rs11615 polymorphism and clinical outcomes of oxaliplatin-based chemotherapies in gastrointestinal cancer: a meta-analysisHigh expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapyEnhanced nucleotide excision repair capacity in lung cancer cells by preconditioning with DNA-damaging agents.Association of single nucleotide polymorphisms in the MVP gene with platinum resistance and survival in patients with epithelial ovarian cancerMAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors.The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naïve patients with germ cell cancer.Cisplatin resistance in germ cell tumours: models and mechanisms.Cisplatin Toxicity in Dorsal Root Ganglion Neurons Is Relieved by Meclizine via Diminution of Mitochondrial Compromise and Improved Clearance of DNA Damage.Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.Exploring the molecular aspects associated with testicular germ cell tumors: a review.Nucleotide Excision Repair: From Neurodegeneration to Cancer.Computational Characterization of Small Molecules Binding to the Human XPF Active Site and Virtual Screening to Identify Potential New DNA Repair Inhibitors Targeting the ERCC1-XPF Endonuclease.The chemosensitivity of testicular germ cell tumors.
P2860
Q26739398-93A7F068-4070-489E-AA32-C5E4407D7CE9Q26863585-A47CAA75-4B25-4072-8787-1C836B1CC91FQ34990550-5F0991F8-B43B-4174-9485-A4DBB09D84C4Q35194655-190D6B92-C3FB-4F0F-8853-E6C8CC5D9A9CQ35686424-DEE85133-4F0D-435A-8714-63BB75D39107Q35759077-71AFE84F-8EA8-449E-A0FA-5B3938729040Q36742188-3FF8CB07-32E2-426D-AF97-080354A96B27Q37143221-373D94EC-0590-4F75-8360-E14D84E7B7DFQ37689056-58EE4D54-F94D-475C-95F0-C3A973102952Q38302534-2CF7D615-21CD-4173-8F09-7CD6B806FAFAQ39178503-863C6EF0-81E5-4474-B67E-E5466B3ED84DQ43749889-5F620436-BE29-418B-99A8-63B98EE46AAFQ49610684-EB7C4CB0-E95A-4FE5-901A-98EA931BF746Q50428930-B82D78AC-D94F-4475-8D41-DA7BB1B3D1F6Q52715489-0070BAAE-95DB-4A9D-92FE-92FAA53935BCQ53059668-46A43B79-6B09-4AE3-9278-1B76B713060F
P2860
Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Association between ERCC1 and ...... testicular germ cell tumours.
@ast
Association between ERCC1 and ...... testicular germ cell tumours.
@en
Association between ERCC1 and ...... testicular germ cell tumours.
@nl
type
label
Association between ERCC1 and ...... testicular germ cell tumours.
@ast
Association between ERCC1 and ...... testicular germ cell tumours.
@en
Association between ERCC1 and ...... testicular germ cell tumours.
@nl
prefLabel
Association between ERCC1 and ...... testicular germ cell tumours.
@ast
Association between ERCC1 and ...... testicular germ cell tumours.
@en
Association between ERCC1 and ...... testicular germ cell tumours.
@nl
P2093
P2860
P50
P356
P1476
Association between ERCC1 and ...... n testicular germ cell tumours
@en
P2093
C Hernández
E Fabián-Morales
J Martínez
L A Herrera
M A Andonegui
M A Jiménez
P2860
P2888
P356
10.1038/BJC.2013.303
P407
P577
2013-06-27T00:00:00Z
P5875
P6179
1006419123